AI-Driven Detection of Cognitive Impairment via Multimodal Biomarkers
August 3, 2026
A new taxonomy and framework integrates EEG signals, MRI, PET imaging, and blood-based biomarkers using deep learning to detect early-stage mild cognitive impairment. The approach emphasizes subject- and site-independent validation to ensure clinical utility in longitudinal screening.
HOW THIS AFFECTS YOU
●
researcherThe cross-disciplinary taxonomy provides a structured lens for validating site-independent detection models.
●
healthYou can leverage this multi-modal framework to improve early diagnostic accuracy for dementia.